[1]
B. Jahanbin, V. Soleimani, F. Azmoude-Ardalan, S. Afshar, and M. Safaei, “Evaluation of HER2 Gene Amplification using CISH in Patients with HER2 2+ (equivocal) Breast Carcinoma based on Immunohistochemistry in Imam Khomeini Cancer Institute from 2016 to 2018: HER2 amplification in breast carcinoma”, Arch Breast Cancer, vol. 10, no. 2, pp. 131–137, Apr. 2023.